Abstract
BackgroundA growing body of research suggests that methylated genes can be used as early diagnostic markers for cancer. Some studies on methylated Syndecan 2 (SDC2) have shown that it has a great diagnostic ability in colorectal cancer. This meta-analysis was aimed to estimate the diagnostic performance of methylated SDC2 as a potential novel biomarker to screen for the colorectal cancer.MethodsTwo independent researchers conducted a comprehensive literature search to identify all relevant studies on SDC2 methylation for the diagnosis of colorectal cancer from inception to March 1, 2021. By using STATA and Revman software, the data were analyzed using a Bivariate mixed model. The quality of each study was also evaluated.ResultsA total of 12 studies comprised of 1574 colorectal cancer patients and 1945 healthy people were included in our meta-analysis. Bivariate analysis showed a pooled sensitivity of 0.81 [95% confidence interval (CI) 0.74–0.86], specificity of 0.95 (95% CI 0.93–0.96), positive likelihood ratio of 15.29 (95% CI 10.83–21.60), and negative likelihood ratio of 0.21 (95% CI 0.15–0.27). The diagnostic odds ratio and the area under the summary ROC curve for diagnosing colorectal cancer were 74.42 (95% CI45.44–121.89) and 0.96 (95% CI 0.94–0.97), respectively. For adenomas, the pooled sensitivity and specificity were 0.47 (95% CI 0.34–0.61) and 0.95 (95% CI 0.92–0.97), respectively.ConclusionsOur analysis revealed that methylated SDC2 could be considered as a potential novel biomarker to screen for colorectal cancer.
Full Text
Topics from this Paper
Syndecan 2
Colorectal Cancer
Test In Colorectal Cancer Screening
Confidence Interval
Bivariate Mixed Model
+ Show 5 more
Create a personalized feed of these topics
Get StartedSimilar Papers
Gastroenterology
Jul 1, 2017
The Cochrane database of systematic reviews
Jun 6, 2022
Cochrane Database of Systematic Reviews
Jun 6, 2022
Cancer Nursing
Jul 1, 2014
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Jan 8, 2009
Cancer Epidemiology, Biomarkers & Prevention
Jun 1, 2004
Gastroenterology
May 1, 2005
Gastroenterology
Dec 1, 2004
Cancer Epidemiology, Biomarkers & Prevention
Jun 1, 2012
Gastroenterology
Jun 1, 2007
Gastroenterology
Nov 1, 2011
Clinical Gastroenterology and Hepatology
Jan 1, 2015
European Journal of Gastroenterology & Hepatology
Sep 1, 2014
Annals of Oncology
Jan 19, 2002
Public Health
Sep 1, 2011
BMC Gastroenterology
BMC Gastroenterology
Oct 2, 2023
BMC Gastroenterology
Oct 2, 2023
BMC Gastroenterology
Sep 30, 2023
BMC Gastroenterology
Sep 28, 2023
BMC Gastroenterology
Sep 28, 2023
BMC Gastroenterology
Sep 28, 2023
BMC Gastroenterology
Sep 27, 2023
BMC Gastroenterology
Sep 27, 2023
BMC Gastroenterology
Sep 27, 2023
BMC Gastroenterology
Sep 27, 2023